MARKET

ABMD

ABMD

Abiomed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

301.22
+5.59
+1.89%
After Hours: 301.22 0 0.00% 17:29 03/05 EST
OPEN
296.50
PREV CLOSE
295.63
HIGH
302.57
LOW
281.00
VOLUME
412.13K
TURNOVER
--
52 WEEK HIGH
387.40
52 WEEK LOW
119.01
MARKET CAP
13.62B
P/E (TTM)
68.54
1D
5D
1M
3M
1Y
5Y
Abiomed Inc. stock rises Friday, still underperforms market
Shares of Abiomed Inc. rallied 1.89% to $301.22 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...
marketwatch.com · 11h ago
MEDCERT Enables the Use of the Single Access Procedure with Impella CP Introducer Sheaths in Europe
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment of heart disease in Europe.
Business Wire · 1d ago
Global Cardiac Assist Devices Market Will Grow At A CAGR Of 11.6% During The Forecast Period 2020-2027
Japan, Japan, Thu, 04 Mar 2021 02:29:49 / Comserve Inc. / -- Key vendors: Abbott Laboratories, Berlin Heart GmbH, Maquet GmbH (Getinge AB), ReliantHeart,...
Comserve · 2d ago
Abiomed Inc. stock falls Wednesday, underperforms market
Shares of Abiomed Inc. slid 5.44% to $307.60 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 2d ago
What Do The Returns On Capital At Abiomed (NASDAQ:ABMD) Tell Us?
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Simply Wall St. · 4d ago
Abiomed Inc. stock underperforms Monday when compared to competitors
Shares of Abiomed Inc. dropped 0.09% to $324.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 4d ago
Abiomed (ABMD) Down 8.6% Since Last Earnings Report: Can It Rebound?
Zacks.com · 6d ago
Abiomed (ABMD) Down 8.6% Since Last Earnings Report: Can It Rebound?
Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABMD. Analyze the recent business situations of Abiomed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABMD stock price target is 378.00 with a high estimate of 425.00 and a low estimate of 245.00.
EPS
Institutional Holdings
Institutions: 784
Institutional Holdings: 48.00M
% Owned: 106.11%
Shares Outstanding: 45.23M
TypeInstitutionsShares
Increased
163
1.88M
New
115
-97.82K
Decreased
183
1.93M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Director/President/Chief Executive Officer
Michael Minogue
Chief Financial Officer/Vice President
Todd Trapp
Chief Operating Officer/Senior Vice President
David Weber
Vice President/General Counsel/Secretary
Marc Began
Vice President/General Manager
Michael Howley
Vice President
Andrew Greenfield
Lead Director/Independent Director
Dorothy Puhy
Director
Myron Rolle
Independent Director
Jeannine Rivet
Independent Director
Eric Rose
Independent Director
Martin Sutter
Independent Director
Paul Thomas
Independent Director
Christopher Van Gorder
No Data
About ABMD
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Webull offers kinds of ABIOMED, Inc. stock information, including NASDAQ:ABMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABMD stock methods without spending real money on the virtual paper trading platform.